Lula's progress plan for Brazil, tracking opioid lawsuit settlements in the US, the cell & gene therapy landscape in the US, ...

Otsuka Pharmaceutical has axed the development of its dementia drug, AVP-786, following a disappointing Phase III readout ...

Boehringer and OSE have also expanded two solid tumour programmes into cardiovascular-renal-metabolic (CRM) indications.

AstraZeneca has entered into a worldwide licence and option agreement with Nona Biosciences for a preclinical monoclonal ...

Experts at the OCT East Coast 2024 conference discussed the challenges and solutions for diverse recruitment, particularly as ...

Biogen has signed a definitive agreement to acquire Human Immunology Biosciences (HI-Bio) in a deal worth $1.8bn.

The EC has granted marketing authorisation for Sandoz’s biosimilars, Wyost (denosumab) and Jubbonti (denosumab) for ...

In the existing drug development ecosystem, patients and caregivers are bucking the natural order to take the reins of ...

MilliporeSigma operators monitoring viral vector production in a bioreactor in its Carlsbad, California manufacturing ...

How many patents did Memorial Sloan Kettering Cancer Center submit related to artificial intelligence last quarter, and how many were granted? Discover the latest information here.

AstraZeneca has the option to acquire SixPeaks in the next two years if the latter’s bispecific antibody proves successful.

As the nitrosamine scandal continues, we explore the advancements in parenteral packaging materials that are reducing the ...